Skip to main content

Anti-Cancer Light-Controllable Antibody-Peptide Conjugates

Project description

Selectively enhancing antibodies through light irradiation

Monoclonal antibodies have been considered a significant weapon against cancer since the beginning of the 20th century. After decades of research, medicine has managed to eliminate their adverse reactions to patients and develop revolutionary cancer therapies. The EU-funded ALISE project will focus on the possibility of boosting the anticancer activity only in tumours. To this aim, researchers will design and synthesise light-controllable conjugates of monoclonal antibodies with peptides whose anticancer activity can be enhanced in tumours by irradiation with light. In this project, seven leading institutions with significant expertise, resources and knowledge on design, synthesis and preclinical study in this field will join forces to contribute to innovative and safer therapeutic strategies.

Coordinator

ENAMINE LIMITED LIABILITY COMPANY,RESEARCH AND PRODUCTION ENTERPRISE
Net EU contribution
€ 303 600,00
Address
78 Chervonotkatska Str.
02094 Kyiv
Ukraine

See on map

Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00

Participants (6)

KARLSRUHER INSTITUT FUER TECHNOLOGIE
Germany
Net EU contribution
€ 73 600,00
Address
Kaiserstrasse 12
76131 Karlsruhe

See on map

Region
Baden-Württemberg Karlsruhe Karlsruhe, Stadtkreis
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
United Kingdom
Net EU contribution
€ 27 600,00
Address
Trinity Lane The Old Schools
CB2 1TN Cambridge

See on map

Region
East of England East Anglia Cambridgeshire CC
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
LATVIJAS ORGANISKAS SINTEZES INSTITUTS
Latvia
Net EU contribution
€ 55 200,00
Address
Aizkraukles 21
LV-1006 Riga

See on map

Region
Latvija Latvija Rīga
Activity type
Research Organisations
Non-EU contribution
€ 0,00
NATIONAL CANCER INSTITUTE
Ukraine
Net EU contribution
€ 55 200,00
Address
33/43 Lomonosova Street
03022 Kiyv

See on map

Activity type
Research Organisations
Non-EU contribution
€ 0,00
LUMOBIOTICS GmbH
Germany
Net EU contribution
€ 165 600,00
Address
Auerstrasse 2
76227 Karlsruhe

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Baden-Württemberg Karlsruhe Karlsruhe, Stadtkreis
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
STICHTING VUMC
Netherlands
Net EU contribution
€ 64 400,00
Address
De Boelelaan 1117
1081 HV Amsterdam

See on map

Region
West-Nederland Noord-Holland Groot-Amsterdam
Activity type
Research Organisations
Non-EU contribution
€ 0,00